MAPK6 and cancer: Based on the results of this study, we propose a novel molecular mechanism for the upregulation of ERK3 in cancer: BMI1 suppresses the transcription of the miRNA let‐7i, a negative regulator of ERK3 expression, which leads to elevation in ERK3 protein level and increase in cancer cell migration (Fig. 7).